Vector Science and Therapeutics Corp. (PAIN : TSX-V)
Common Stock
$2.38
CAD
-0.09 (-3.64%)
Last updated: 2026-06-26
PAIN
Vector Science and Therapeutics Corp.
WealthAwesomePerformance
1 Day
-3.64%
1 Week
-3.64%
1 Month
+83.08%
YTD
+390.72%
Key Statistics
Market Cap
$13.09M
52W High
$2.65
52W Low
$0.35
P/E Ratio
-
50 Day MA
$1.47
200 Day MA
$1.47
Beta
4.68
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/26/2026 | $2.42 | $2.44 | $2.29 | $2.38 | $2.38 | 127,722 |
| 6/25/2026 | $2.36 | $2.47 | $2.28 | $2.47 | $2.47 | 164,341 |
| 6/24/2026 | $2.42 | $2.48 | $2.33 | $2.42 | $2.42 | 314,092 |
| 6/23/2026 | $2.44 | $2.44 | $2.32 | $2.43 | $2.43 | 128,305 |
| 6/22/2026 | $2.38 | $2.50 | $2.38 | $2.48 | $2.48 | 135,995 |
| 6/19/2026 | $2.49 | $2.65 | $2.45 | $2.47 | $2.47 | 368,218 |
| 6/18/2026 | $2.47 | $2.49 | $2.28 | $2.49 | $2.49 | 481,356 |
| 6/17/2026 | $2.18 | $2.49 | $2.15 | $2.49 | $2.49 | 593,033 |
| 6/16/2026 | $2.17 | $2.19 | $2.03 | $2.18 | $2.18 | 226,209 |
| 6/15/2026 | $1.91 | $2.18 | $1.85 | $2.18 | $2.18 | 489,041 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PAIN's historical volatility
30-Day Vol
98.6%
Annualized
90-Day Vol
110.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.85
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.53 | C$1.80 – C$3.55 |
| 60 trading days | C$2.68 | C$1.66 – C$4.34 |
| 90 trading days | C$2.85 | C$1.58 – C$5.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Vector Science and Therapeutics Corp.
Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration. The company has a development and manufacturing agreement with MPP Group LLC to develop and manufacture pharmaceutical-grade peptides and drug delivery devices. The company is based in Mequon, Wisconsin.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- -104.10%
- EPS (Diluted)
- -0.49
- Book Value
- 0.09
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About PAIN
Articles Featuring PAIN.V
Latest articles and analysis covering PAIN.V
